Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Jul 31, 2014, during market hours
10-Q filed Jul 31, 2014, 31 days after period end · 0001396814-14-000009
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $47.17M | $17.14M | $12.34M | $3.64M |
| Net Income | -$5.04M | -$14.03M | -$8.30M | -$8.76M |
| EPS Diluted | -$0.14 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.42 |
| -$0.27 |
| -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.